ArticleInternational cancer conference journal2026
Ewing sarcoma of the frontal sinus in an elderly patient: a case report and review.
Article in International cancer conference journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ewing sarcoma is a malignant small round cell tumor with an aggressive clinical course that typically arises in the extremities or trunk of adolescents and young adults. Sinonasal Ewing sarcoma in elderly patients is extremely rare, and its diagnosis can be challenging owing to overlapping histopathological features with other malignancies. A 71-year-old woman with a sinonasal tumor was referred to our hospital. The initial pathological diagnosis based on an outpatient biopsy was olfactory neuroblastoma (ONB). However, the absence of tumor in the olfactory cleft suggested other histological types. A surgical biopsy was performed, and Ewing sarcoma was confirmed by immunostaining and fluorescence in situ hybridization. One month after surgical biopsy, rapid tumor growth with intracranial extension was observed. Chemotherapy and extensive skull-base surgery were declined. Although carbon-ion radiotherapy was effective for the primary tumor, bone metastases developed shortly after treatment, and the patient died 7 months after the initial visit. This case highlights the diagnostic pitfalls of sinonasal malignancies and the importance of endoscopic and radiologic findings as potential diagnostic clues. In frontal sinus Ewing sarcoma, local treatment alone is unlikely to achieve cure without chemotherapy. However, the standard regimen for Ewing sarcoma is often too toxic for elderly patients, underscoring the need for more tolerable treatment options. To our knowledge, this is the first reported case of frontal sinus Ewing sarcoma in a patient over 60 years old.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.